glp-1 dual agonist GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes Dual GLP-1/GIP receptor agonists mechanism

Building muscle or trying to maintain muscle mass requires effort, but it is critical when adhering to a reduced calorie diet

Guidance for Industry: drug interaction studiesstudy design, data analysis, implications for dosing, and labeling recommendations

Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial [published correction appears in Arch Ophthalmol 1998 Nov;116(11):1469]

The UKs National Institute for Health and Care Excellence and European Medicines Agency approved dapagliflozin as an adjunctive treatment of type 1 diabetes in 2019 and 2018, respectively [26, 27]

Systemic and Structural Inequities

Which GLP-1 medications does Anthem cover